Autori: Popovic Djordje S
Naslov | Ezetimibe and Insulin Resistance (Editorial Material) |
Autori | Popovic Djordje S Papachristou Stella Stokic Edita J Papanas Nikolaos |
Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 315-317 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region? (Editorial Material) |
Autori | Popovic Djordje S Stokic Edita J Stoian Anca Pantea Papanas Nikolaos |
Info | CURRENT VASCULAR PHARMACOLOGY, (2022), vol. 20 br. 4, str. 311-312 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
Naslov | Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention (Editorial Material) |
Autori | Popovic Djordje S Koufakis Theocharis Kovacevic Bojan Rizzo Manfredi Papanas Nikolaos |
Info | EXPERT OPINION ON DRUG SAFETY, (2022), vol. 21 br. 11, str. 1337-1339 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | The importance of sleep quality, quantity, and chronotype in the management of diabetes: Is it time to wake up? (Letter) |
Autori | Koufakis Theocharis Maltese Giuseppe Popovic Djordje S Kotsa Kalliopi |
Info | JOURNAL OF DIABETES, (2022), vol. 14 br. 9, str. 633-634 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Double Diabetes: A Growing Problem Requiring Solutions (Article) |
Autori | Popovic Djordje S Papanas Nikolaos |
Info | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, (2022), vol. 130 br. 04, str. 268-274 |
Projekat | Eli LillyEli Lilly; MSD; Novo NordiskNovo Nordisk; NovartisNovartis; Sanofi-AventisSanofi-Aventis |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises? (Editorial Material) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | ADVANCES IN THERAPY, (2022), vol. 39 br. 6, str. 2283-2286 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | The Role of Fructose as a Cardiovascular Risk Factor: An Update (Article) |
Autori | Busnatu Stefan-Sebastian Salmen Teodor Pana Maria-Alexandra Rizzo Manfredi Stallone Tiziana Papanas Nikolaos Popovic Djordje S Tanasescu Denisa Serban Dragos Stoian Anca Pantea |
Info | METABOLITES, (2022), vol. 12 br. 1, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | One-hour Post-load Plasma Glucose Cut-off Value for Diagnosing Diabetes: Do the New Data Bring us Closer to the Answer? (Letter) |
Autori | Popovic Djordje S Papanas Nikolaos |
Info | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, (2022), vol. 130 br. 05, str. 353-353 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review (Review) |
Autori | Popovic Djordje S Papanas Nikolaos Pantea-Stoian Anca Rizvi Ali A Janez Andrej Rizzo Manfredi |
Info | DIABETES THERAPY, (2021), vol. 12 br. 12, str. 3037-3054 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
Naslov | The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright? (Editorial Material) |
Autori | Papachristou Stella Popovic Djordje S Papanas Nikolaos |
Info | DIABETES-METABOLISM RESEARCH AND REVIEWS, (2021), vol. 37 br. 8, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |